877 related articles for article (PubMed ID: 17229439)
1. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA
J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439
[TBL] [Abstract][Full Text] [Related]
2. Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition.
Henderson KA; Streltsov VA; Coley AM; Dolezal O; Hudson PJ; Batchelor AH; Gupta A; Bai T; Murphy VJ; Anders RF; Foley M; Nuttall SD
Structure; 2007 Nov; 15(11):1452-66. PubMed ID: 17997971
[TBL] [Abstract][Full Text] [Related]
3. Expression, crystallization and preliminary structural analysis of the ectoplasmic region of apical membrane antigen 1 from Plasmodium vivax, a malaria-vaccine candidate.
Vulliez-Le Normand B; Pizarro JC; Chesne-Seck ML; Kocken CH; Faber B; Thomas AW; Bentley GA
Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):2040-3. PubMed ID: 15502321
[TBL] [Abstract][Full Text] [Related]
4. Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.
Cortés A; Mellombo M; Masciantonio R; Murphy VJ; Reeder JC; Anders RF
Infect Immun; 2005 Jan; 73(1):422-30. PubMed ID: 15618180
[TBL] [Abstract][Full Text] [Related]
5. Structure and inter-domain interactions of domain II from the blood-stage malarial protein, apical membrane antigen 1.
Feng ZP; Keizer DW; Stevenson RA; Yao S; Babon JJ; Murphy VJ; Anders RF; Norton RS
J Mol Biol; 2005 Jul; 350(4):641-56. PubMed ID: 15964019
[TBL] [Abstract][Full Text] [Related]
6. Apical membrane antigen 1: a malaria vaccine candidate in review.
Remarque EJ; Faber BW; Kocken CH; Thomas AW
Trends Parasitol; 2008 Feb; 24(2):74-84. PubMed ID: 18226584
[TBL] [Abstract][Full Text] [Related]
7. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium vivax, P. cynomolgi, and P. knowlesi: identification of homologue proteins associated with the surface of merozoites.
Barnwell JW; Galinski MR; DeSimone SG; Perler F; Ingravallo P
Exp Parasitol; 1999 Mar; 91(3):238-49. PubMed ID: 10072326
[TBL] [Abstract][Full Text] [Related]
9. A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.
Burns JM; Majarian WR; Young JF; Daly TM; Long CA
J Immunol; 1989 Oct; 143(8):2670-6. PubMed ID: 2477452
[TBL] [Abstract][Full Text] [Related]
10. Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum.
Healer J; Murphy V; Hodder AN; Masciantonio R; Gemmill AW; Anders RF; Cowman AF; Batchelor A
Mol Microbiol; 2004 Apr; 52(1):159-68. PubMed ID: 15049818
[TBL] [Abstract][Full Text] [Related]
11. A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice.
Gentil F; Bargieri DY; Leite JA; Françoso KS; Patricio MB; Espíndola NM; Vaz AJ; Palatnik-de-Sousa CB; Rodrigues MM; Costa FT; Soares IS
Vaccine; 2010 Aug; 28(38):6183-90. PubMed ID: 20654667
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of Plasmodium knowlesi apical membrane antigen 1 and its complex with an invasion-inhibitory monoclonal antibody.
Vulliez-Le Normand B; Faber BW; Saul FA; van der Eijk M; Thomas AW; Singh B; Kocken CH; Bentley GA
PLoS One; 2015; 10(4):e0123567. PubMed ID: 25886591
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium vivax: a monoclonal antibody recognizes a circumsporozoite protein precursor on the sporozoite surface.
Gonzalez-Ceron L; Rodriguez MH; Wirtz RA; Sina BJ; Palomeque OL; Nettel JA; Tsutsumi V
Exp Parasitol; 1998 Nov; 90(3):203-11. PubMed ID: 9806864
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of Plasmodium falciparum apical membrane antigen 1 utilizing interspecies domains.
Healer J; Triglia T; Hodder AN; Gemmill AW; Cowman AF
Infect Immun; 2005 Apr; 73(4):2444-51. PubMed ID: 15784590
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
[TBL] [Abstract][Full Text] [Related]
17. Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.
Dutta S; Dlugosz LS; Drew DR; Ge X; Ababacar D; Rovira YI; Moch JK; Shi M; Long CA; Foley M; Beeson JG; Anders RF; Miura K; Haynes JD; Batchelor AH
PLoS Pathog; 2013; 9(12):e1003840. PubMed ID: 24385910
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the malaria vaccine candidate apical membrane antigen 1.
Pizarro JC; Vulliez-Le Normand B; Chesne-Seck ML; Collins CR; Withers-Martinez C; Hackett F; Blackman MJ; Faber BW; Remarque EJ; Kocken CH; Thomas AW; Bentley GA
Science; 2005 Apr; 308(5720):408-11. PubMed ID: 15731407
[TBL] [Abstract][Full Text] [Related]
19. Structures of phage-display peptides that bind to the malarial surface protein, apical membrane antigen 1, and block erythrocyte invasion.
Keizer DW; Miles LA; Li F; Nair M; Anders RF; Coley AM; Foley M; Norton RS
Biochemistry; 2003 Aug; 42(33):9915-23. PubMed ID: 12924940
[TBL] [Abstract][Full Text] [Related]
20. A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design.
Amante FH; Crewther PE; Anders RF; Good MF
J Immunol; 1997 Dec; 159(11):5535-44. PubMed ID: 9548494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
